Professional
HTA data for quarter three of 2023 to 2024
Today we are publishing data about incidents reported to HTA during quarter three of 2023 to 2024. We are also publishing our workforce and expenses information.
HTA licensed establishments in the Post Mortem, Human Application and Organ Donation and Transplantation sector are required to report incidents to the HTA as part of their licensing requirements.
In the post-mortem sector we call these HTARIs, and those in the Human Application and Organ Donation and Transplantation sectors are called Serious Adverse Events or Reactions (SAEARs).
Working in University research
I am Designated Individual (DI) for the University of Warwick’s HTA Research Licence, which covers two sites, one at the University campus and the other in laboratory space that the University rents from a local NHS Trust. We have five departments where human tissue is used in research, with great diversity in the projects, tissue types and characters involved in the research.
HTA Board - 7 December 2023
Human Tissue Authority Board Meeting
HTA publish licence fee levels for the 2023 to 2024 business year
As an executive agency of the Department of Health & Social Care (DHSC), we are funded from Grant-in-Aid from the DHSC and devolved administrations and through licence fees charged to licensed establishments.
Trafficking for the purpose of organ harvesting
Human Tissue Authority Chief Executive speaks at conference about Trafficking for the purpose of organ harvesting
Evaluated self-assessments
At the HTA, we have used different inspection models over the years although our core approach has been a site-based inspection, typically with two inspecting staff.
Human Tissue Authority welcomes three new Board members
The Human Tissue Authority (HTA) is pleased to announce that the Secretary of State for Health and Social Care has appointed three new Board members for the Authority. They will join the HTA with effect from 1st December 2023.
Chair of the HTA, Lynne Berry CBE, has commented: